PMC:7784830 / 9698-9925 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"169","span":{"begin":28,"end":33},"obj":"Species"},{"id":"181","span":{"begin":102,"end":118},"obj":"Disease"}],"attributes":[{"id":"A169","pred":"tao:has_database_id","subj":"169","obj":"Tax:9606"},{"id":"A181","pred":"tao:has_database_id","subj":"181","obj":"OMIM:176500"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"APN01 – Recombinant form of human angiotensin convertase enzyme 2. Dr. Josef Penninger, University of British Columbia, has carried out extensive research on APN01 in collaboration with various companies and academic institutes"}